# EDGAR Filing Document

**Accession Number:** 0001822359
**File Stem:** 0001213900-23-022085
**Filing Date:** 2023-3
**Character Count:** 5969
**Document Hash:** 4fe0c7d7bc004de32956dafe24bc7505
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-022085.hdr.sgml**: 20230322

**ACCESSION NUMBER**: 0001213900-23-022085

**CONFORMED SUBMISSION TYPE**: 8-K/A

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20221106

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230322

**DATE AS OF CHANGE**: 20230322

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DocGo Inc.
- **CENTRAL INDEX KEY:** 0001822359
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **IRS NUMBER:** 852515483
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39618
- **FILM NUMBER:** 23753143

**BUSINESS ADDRESS:**
- **STREET 1:** 35TH STREET WEST 35TH
- **STREET 2:** FLOOR 6
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001
- **BUSINESS PHONE:** (844) 443-6246

**MAIL ADDRESS:**
- **STREET 1:** 35TH STREET WEST 35TH
- **STREET 2:** FLOOR 6
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Motion Acquisition Corp.
- **DATE OF NAME CHANGE:** 20200824

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K/A**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): November 6, 2022**

**DOCGO INC.** 

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39618** | **85-2515483** |
| **(State or other jurisdiction <br> of incorporation)** | **(Commission File Number)** | **(IRS Employer <br> Identification No.)** |

---

---

| | |
|:---|:---|
| **35 West 35th Street, Floor 6, New York, New York** | **10001** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**(844) 443-6246**

**(Registrant's telephone number, including area code)**

**N/A** 

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on**<br> **which registered** |
| **Common stock, par value $0.0001 per share** | **DCGO** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

This Current Report on Form 8-K/A amends Item 5.02 of the Current Report on Form 8-K filed on November 7, 2022 (the "Report") by DocGo Inc. (the "Company") to add the information described herein.

 **Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On November 7, 2022, the Company filed the Report to disclose that, effective December 31, 2022, the Board of Directors (the "Board") of the Company appointed Mr. Anthony Capone as the Company's Chief Executive Officer. In consideration of this promotion, on March 18, 2023, the Board, upon recommendation by the Compensation Committee (the "Committee") of the Board, approved an increase of Mr. Capone's base salary from $425,000 to $600,000 and his target annual bonus from 73% of base salary to 100% of base salary, each to be effective April 1, 2023.

In addition, on March 16, 2023, the Committee approved the grant of fully vested stock to Mr. Capone, with a grant date fair value of approximately $43,750, which reflects the amount that would have been paid to Mr. Capone if the base salary increase were made retroactive to January 1, 2023. On the same date, the Committee also approved the grant of an additional stock option award to Mr. Capone, with a grant date fair value of approximately $366,000, which will vest in equal annual installments over four years. The stock award and the stock options will be effective on the third trading day following the date the Company files its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023.

**Item 9.01** **Financial Statements and Exhibits.**

*(d) Exhibits*

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| **DOCGO INC.** | **DOCGO INC.** | **DOCGO INC.** |
| By: | /s/ Anthony Capone | /s/ Anthony Capone |
|  | Name: | Anthony Capone |
|  | Title: | Chief Executive Officer |

---

Date: March 22, 2023